Member Info for BuenaVista

D-Geeman - it's reported as university 'hospital' research treatments because it's the clinicians that do the clinical work. Simple as that. Oftentimes the company behind the treatment doesn't even get a mention in the media report.

The full press release on which The Times article woud have been based: https://www.england.nhs.uk/2025/11/personalised-living-drug-to-offer-hope-of-cure-for-aggressive-leukaemia-on-nhs/

It's our near-neighbour Autolus. Here's their press release: https://www.marketwatch.com/press-release/nice-recommends-aucatzyl-r-obecabtagene-autoleucel-as-a-treatment-option-for-adult-patients-26-years-with-relapsed-or-refractory-b-cell-precursor-acute-lymphoblastic-leukemia-r-r-b-all-1-c88be0f9

Yes, a completely unrelated and unimpinging cancer area, but the reason why it was featured in The Times is obvious - a new treatment on the NHS.

The RNS said:

"Potential partners who have expressed an interest in P140 range in size and scope and include a number of top ten global Pharma companies. A number of parties have signed Confidential Disclosure Agreements."

At least two top ten global Pharma companies and at least one other had expressed 'interest'. At least two companies, not necessarily any of them top ten global Pharma companies, 'have signed' CDAs.

One would assume, even with AIM's lax grip on truth, that 'interest' means some level of positive interaction, and that 'have signed' means the CDAs are still in force.

Coming from you SmTch73 I'll take that as a badge of honour. Now, in the bin you go.

Hmm... The projection is strong in that one.

What seems at first sight like a naive or dumb question is really just a crude attempt at spreading FUD to effect sentiment.

I'm very concerned about 40 June 2026. We all should be. Ominous...

There's a Bank Holiday this week?

You can know a person by their posting history... Rainbow-chasing traders such as @quickwin08

"Not even the Sunday sermon could raise my spirits today"

It's a long time till Sunday. Tomorrow the share price could bounce back, do a dead cat bounce, or continue on down. These are the concerns of traders. Who knows where the share price will be come Sunday, or the Sunday after, or after that, and so on? Personally, I regarded the reaction to today's announcement as a buying (in) opportunity. My time horizon is 5 April 2026 and beyond. Strong IP is so vital in biopharma.

It's Derek selling down hs 35p holding in readiness for the 20p raise.

It always takes longer than planned/hoped for. Particularly when the number of options increases.

RNS, 7 March 2025: "The Company anticipates providing a further update from the Phase 1a dose escalation data in 2Q 2025 and Phase 1b dose expansion cohort data at the end of 2025."

https://avacta.com/avacta-announces-promising-early-efficacy-and-safety-data-for-ava6000-in-the-phase-1a-dose-escalation-and-ongoing-enrollment-in-the-phase-1b-expansion-cohorts/

- - - - -

Interim Results, 30 September 2025: "FAP-Dox (Program 1) Data Catalysts: Updated data in late 2025 in salivary gland cancer (on track)"

https://avacta.com/wp-content/uploads/2025/09/Avacta_Interims_30Sept2025.pdf (slide 7: Upcoming Key Data Catalysts 2025-2026)

.

Derek desperately wants to be in a gang. Pathetic little weasel.

You're pathetic

Bore off Junior

yes. they're just a bunch of pathetic ******s, long past their best before date.

Anyone who gives the three amigos credit deserves all that's coming to them.😂 The pre|CISION platform was proven a long time ago when the dipeptide was shown to be exquisitely specific for FAP. Now, it's all just playing out with new IP to logically extend the pipeline.

Just a litany of lies there from the pub bore, as usual. Too tedious to refute.

Looks like Derek's self-dosing with Tedium as well.